VASH1 and type 2 diabetes mellitus: Contrastingly, immunohistochemical displayed TGFβ1 has also been significantly suppressed, proving that VASH-1 has the inhibitory effect of renal interstitial fibrosis in type 2 diabetes (Shao et al., 2016).